Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Schneider, Ines ^a   Lehmann, Mandy D ^a   Kogosov, Vlada ^b   Stockfleth, Eggert ^a   Nindl, Ingo ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Actinic keratosis (AK); Cutaneous human papillomavirus (HPV); Eyebrow hairs; Natural history

Indexed keywords

DNA;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BETAPAPILLOMAVIRUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; EYEBROW; GAMMAPAPILLOMAVIRUS; HAIR ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; SKIN BIOPSY; SKIN DEFECT; VIRAL SKIN DISEASE; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

AGED; AGED, 80 AND OVER; BIOPSY; DNA, VIRAL; EYEBROWS; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SKIN;

EID: 84876664527     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-186     Document Type: Article

References (41)

1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27. 10.1016/j.virol.2004.03.033, 15183049.
2. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79. 10.1016/j.virol.2010.02.002, 3400342, 20206957.
3. International Agency for Research on Cancer IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. IARC Lyon France 1995, 64. International Agency for Research on Cancer.
4. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350. 10.1038/nrc798, 12044010.
5. Proby CM, Harwood CA, Neale RE, Green AC, Euvrard S, Naldi L, Tessari G, Feltkamp MC, de Koning MN, Quint WG, Waterboer T, Pawlita M, Weissenborn S, Wieland U, Pfister H, Stockfleth E, Nindl I, Abeni D, Schegget JT, Bouwes Bavinck JN. A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant 2011, 11:1498-1508. 10.1111/j.1600-6143.2011.03589.x, 21718442.
6. Struijk L, Bouwes Bavinck JN, Wanningen P, van der Meijden E, Westendorp RG, Ter Schegget J, Feltkamp MC. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol 2003, 121:1531-1535. 10.1046/j.1523-1747.2003.12632.x, 14675206.
7. Bouwes Bavinck JN, Neale RE, Abeni D, Euvrard S, Green AC, Harwood CA, de Koning MN, Naldi L, Nindl I, Pawlita M, Pfister H, Proby CM, Quint WG, ter Schegget J, Waterboer T, Weissenborn S, Feltkamp MC. Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 2010, 70:9777-9786. 10.1158/0008-5472.CAN-10-0352, 21098702.
8. Muschik D, Braspenning-Wesch I, Stockfleth E, Rosl F, Hofmann TG, Nindl I. Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2. PLoS One 2011, 6:e27655. 10.1371/journal.pone.0027655, 3218003, 22110707.
9. Akgül B, Garcia-Escudero R, Ghali L, Pfister HJ, Fuchs PG, Navsaria H, Storey A. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res 2005, 65:2216-2223. 10.1158/0008-5472.CAN-04-1952, 15781634.
10. Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarre M, de Villiers EM, Filotico R, Boukamp P, Tommasino M. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 2003, 77:2195-2206. 10.1128/JVI.77.3.2195-2206.2003, 140944, 12525654.
11. Iftner T, Elbel M, Schopp B, Hiller T, Loizou JI, Caldecott KW, Stubenrauch F. Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J 2002, 21:4741-4748. 10.1093/emboj/cdf443, 126183, 12198176.
12. Jackson S, Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 2000, 19:592-598. 10.1038/sj.onc.1203339, 10698529.
13. Nafz J, Kohler A, Ohnesorge M, Nindl I, Stockfleth E, Rosl F. Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection. J Gen Virol 2007, 88:2670-2678. 10.1099/vir.0.82955-0, 17872518.
14. Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, Smyth N, Fuchs P, Pfister H. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 2005, 65:1394-1400. 10.1158/0008-5472.CAN-04-3263, 15735026.
15. Viarisio D, Mueller-Decker K, Kloz U, Aengeneyndt B, Kopp-Schneider A, Grone HJ, Gheit T, Flechtenmacher C, Gissmann L, Tommasino M. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog 2011, 7:e1002125. 10.1371/journal.ppat.1002125, 3136451, 21779166.
16. Jablonska S, Dabrowski J, Jakubowicz K. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972, 32:583-589.
17. Orth G, Jablonska S, Favre M, Croissant O, Jarzabek-Chorzelska M, Rzesa G. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci U S A 1978, 75:1537-1541. 10.1073/pnas.75.3.1537, 411508, 206906.
18. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997, 36:659-685. 10.1016/S0190-9622(97)80315-5, 9146528.
19. Lazarczyk M, Cassonnet P, Pons C, Jacob Y, Favre M. The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev 2009, 73:348-370. 10.1128/MMBR.00033-08, 2698414, 19487731.
20. Borgogna C, Zavattaro E, De AM, Griffin HM, Dell'oste V, Azzimonti B, Landini MM, Peh WL, Pfister H, Doorbar J, Landolfo S, Gariglio M. Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models. Virology 2012, 423:195-204. 10.1016/j.virol.2011.11.029, 22217391.
21. Meyer T, Arndt R, Christophers E, Nindl I, Stockfleth E. Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev 2001, 25:533-547.
22. de Koning MN, Weissenborn SJ, Abeni D, Bouwes Bavinck JN, Euvrard S, Green AC, Harwood CA, Naldi L, Neale R, Nindl I, Proby CM, Quint WG, Sampogna F, ter Schegget J, Struijk L, Wieland U, Pfister HJ, Feltkamp MC. Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol 2009, 90:1611-1621. 10.1099/vir.0.010017-0, 19321753.
23. Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, Breuer J, Majewski S, Pfister H, Wieland U. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005, 125:93-97. 10.1111/j.0022-202X.2005.23733.x, 15982308.
24. Pfister H. Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003, 52-56.
25. Akgül B, Cooke JC, Storey A. HPV-associated skin disease. J Pathol 2006, 208:165-175. 10.1002/path.1893, 16362995.
26. Nindl I, Gottschling M, Stockfleth E. Human papillomaviruses and non-melanoma skin cancer: Basic virology and clinical manifestations. Dis Markers 2007, 23:247-259.
27. Boxman IL, Berkhout RJM, Mulder LHC, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget JT. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997, 108:712-715. 10.1111/1523-1747.ep12292090, 9129220.
28. de Koning MN, Struijk L, Bavinck JN, Kleter B, ter Schegget J, Quint WG, Feltkamp MC. Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol 2007, 88:1489-1495. 10.1099/vir.0.82732-0, 17412978.
29. Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999, 80:2437-2443.
30. Kohler A, Forschner T, Meyer T, Ulrich C, Gottschling M, Stockfleth E, Nindl I. Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas. Br J Dermatol 2007, 156:1078-1080. 10.1111/j.1365-2133.2007.07809.x, 17381450.
31. Nindl I, Gottschling M, Krawtchenko N, Lehmann MD, Rowert-Huber J, Eberle J, Stockfleth E, Forschner T. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis. Br J Dermatol 2007, 156(Suppl 3):34-39.
32. Brink AA, Lloveras B, Nindl I, Heideman DA, Kramer D, Pol R, Fuente MJ, Meijer CJ, Snijders PJ. Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses. J Clin Microbiol 2005, 43:5581-5587. 10.1128/JCM.43.11.5581-5587.2005, 1287797, 16272490.
33. Nindl I, Kohler A, Gottschling M, Forschner T, Lehmann M, Meijer CJ, Snijders PJ, Stockfleth E. Extension of the typing in a general-primer-PCR reverse-line-blotting system to detect all 25 cutaneous beta human papillomaviruses. J Virol Methods 2007, 146:1-4. 10.1016/j.jviromet.2007.05.022, 17604130.
34. Nindl I, Meyer T, Schmook T, Ulrich C, Ridder R, Audring H, Sterry W, Stockfleth E. Human papillomavirus and overexpression of P16INK4a in nonmelanoma skin cancer. Dermatol Surg 2004, 30:409-414. 10.1111/j.1524-4725.2004.30111.x, 15008871.
35. Nindl I, Kohler A, Meyer T, Forschner T, Meijer CJ, Snijders PJ, Sterry W, Stockfleth E. Detection of human papillomavirus DNA in primary squamous cell carcinoma and metastases. Br J Dermatol 2006, 154:797-799. 10.1111/j.1365-2133.2006.07173.x, 16536843.
36. Weissenborn S, et al. Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients. Med Microbiol Immunol 2012, 201:117-125. 10.1007/s00430-011-0212-3, 21792749.
37. Struijk L, Hall L, van der Meijden E, Wanningen P, Bavinck JN, Neale R, Green AC, ter Schegget J, Feltkamp MC. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006, 15:529-535. 10.1158/1055-9965.EPI-05-0747, 16537712.
38. Plasmeijer EI, Neale RE, de Koning MN, Quint WG, McBride P, Feltkamp MC, Green AC. Persistence of betapapillomavirus infections as a risk factor for actinic keratoses, precursor to cutaneous squamous cell carcinoma. Cancer Res 2009, 69:8926-8931. 10.1158/0008-5472.CAN-09-1186, 19903846.
39. Escutia B, Ledesma E, Serra-Guillen C, Gimeno C, Vilata JJ, Guillen C, Nagore E. Detection of human papilloma virus in normal skin and in superficial and nodular basal cell carcinomas in immunocompetent subjects. J Eur Acad Dermatol Venereol 2011, 25:832-838. 10.1111/j.1468-3083.2010.03875.x, 21054564.
40. Plasmeijer EI, Neale RE, Buettner PG, de Koning MN, ter Schegget J, Quint WG, Green AC, Feltkamp MC. Betapapillomavirus infection profiles in tissue sets from cutaneous squamous cell-carcinoma patients. Int J Cancer 2010, 126:2614-2621.
41. Pfister H, Fuchs PG, Majewski S, Jablonska S, Pniewska I, Malejczyk M. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 2003, 295:273-279. 10.1007/s00403-003-0435-2, 14618345.